CH
Publicaties op Oncologisch.com
NCI9673 (Part B): ETCTN Gerandomiseerde Fase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastat...
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXT...
Metastasegerichte therapie plus intermitterende ADT bij oligometastatisch prostaatcarcinoom: EXTEND fase II